RecruitingPhase 1Phase 2NCT06869252

Autologous Adipose Cells Therapy

Sponsor

CERM INC.

Enrollment

40 participants

Start Date

Aug 1, 2025

Study Type

INTERVENTIONAL

Conditions

Hair Thinning Hair Loss/Baldness Wrinkle Appearance Volume Fine Lines Skin Elasticity Skin Pigmentation Skin Texture

Summary

Autologous Adipose Cell Therapy is a series of process designated to address the demerits of the traditional autologous fat grafting and dermal fillers, while enhancing the versatility and aesthetic outcomes. In this study, the goal is to evaluate the safety and efficacy of Autologous Adipose cell Therapy for skin rejuvenation and hair improvement in human application.

Eligibility

Min Age: 21 YearsMax Age: 80 Years

Inclusion Criteria5

Outpatients who express interest in skin rejuvenation, and/or who are experiencing skin conditions, such as winkles, fine lines, loss of skin elasticity, skin pigmentation, scarring.
Outpatients who are experiencing hair loss or hair thinning
Provision of signed and dated informed consent form
Clearly stated willingness to comply with all the procedures of the study and availability of the study
Female and Male aged between 21 to 80 years old 6 Medical clearance by family doctor

Exclusion Criteria8

Pregnancy or lactation
Known allergic reaction to components of cell culture media
Chronic disease , e.g. cardiovascular disease, diabetes, chronic kidney disease, seizures
Chronic infections, e.g. skin fungi infection, psoriasis
Chronic wound healing
Currently taking hormone therapy
History of cancers and active cancers
Viral infection, e.g. HIV, hepatitis B, influenza, coronaviruses.

Print for Your Doctor

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BIOLOGICALAutologous Adipose Cells Therapy

Participants will receive Autologous Adipose Cells therapy treatment, and the safety and efficacy of the treatment will be monitored by the primary investigator up to 25 weeks.